Irinotecan Hydrochloride (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Irinotecan Hydrochloride drug offered from Sagent Pharmaceuticals. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | irinotecan hydrochloride |
| SUBSTANCE NAME: | IRINOTECAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2014-08-15 |
| END MARKETING DATE: | 0000-00-00 |
Irinotecan Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Irinotecan Hydrochloride from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2014-08-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-230_f3029076-6f11-41e6-9ef7-13e511426269 |
| PRODUCT NDC: | 25021-230 |
| APPLICATION NUMBER: | ANDA090675 |
Other IRINOTECAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
